Does zinc support thyroid hormone metabolism and receptor function?

Thyroid hormone homeostasis is traditionally associated with iodine and selenium, but zinc plays an equally vital, non-overlapping role across the entire hypothalamic-pituitary-thyroid (HPT) axis.

Mechanistic pathways

• HPT Axis Regulation: Zinc modulates upstream thyrotropin-releasing hormone (TRH) synthesis in the hypothalamus via zinc-dependent carboxypeptidases, and also regulates thyroid-stimulating hormone (TSH) synthesis in pituitary cells.
• Peripheral Conversion: Zinc serves as a critical cofactor and structural modulator for type 1 and type 2 deiodinases (D1 and D2), the enzymes that catalyze the peripheral conversion of inactive thyroxine (T4) to biologically active triiodothyronine (T3).
• Receptor Activation: Nuclear thyroid hormone receptors (TRα1 and TRβ) rely on zinc-finger domains within their DNA-binding regions. Zinc deficiency alters receptor conformation, blunting DNA and T3-binding capacity, which impairs downstream gene transcription.

Clinical implications

• Independent Signaling Deficit: Because zinc is structurally required for nuclear receptor binding and TRH/TSH synthesis, deficiency impairs thyroid signaling and end-organ responsiveness even if iodine (the raw substrate) and selenium (the deiodinase catalytic core) are fully adequate.
• Therapeutic Efficacy: Clinical trials in hypothyroid and zinc-deficient populations show that zinc supplementation successfully restores active free T3 levels, optimizes the FT3:FT4 ratio, and helps reverse systemic hypothyroid symptoms.

Bottom line

• Bottom line: Zinc is a mandatory structural and catalytic requirement for thyroid hormone synthesis, peripheral activation, and nuclear receptor binding. Consequently, low zinc levels can severely blunt downstream thyroid signaling and tissue responsiveness even when iodine and selenium statuses are fully adequate.